BioSpace News Archive

Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, in collaboration with the Serum Institute of India Pvt. Ltd., today announced dosing has been initiated in an international, multi-center, randomized placebo-controlled Phase 3 clinical trial of CoviLiv.

Johnson & Johnson Vision Care, Inc.,‡ a global leader in eye health and part of Johnson & Johnson MedTech,§ will present new data on the positive effects of wearing blue-violet light filtering contact lenses* at the 2022 American Academy of Optometry annual meeting in San Diego, October 26 – 29.

Orionis Biosciences today will present preclinical data supporting its Allo-GlueTM protein degradation platform for discovery and rational design of small molecule molecular glues at the 5th Annual Targeted Protein Degradation Summit, taking place October 25 – 28 in Boston.

Provectus Algae announced that it has appointed biotech stalwart Guillaume Barbier, PhD as its Vice President of Research and Development.

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization, released today its fiscal year 2022 third-quarter financial results, announcing that the company’s cumulative revenue in fiscal year 2022 surpassed KRW 2 trillion.

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma Lab” or “the Company”), today announced its results for the third quarter ended September 30, 2022.

Genomma Lab Internacional, S.A.B. de C.V. informs that the Company filed a Notice of Rights with the Mexican Stock Exchange declaring a cash dividend of $0.381679389 Mexican pesos per share on its common stock representing a total amount of $ 400,000,000.00 M.N., payable to shareholders of record at the close of business on November 11, 2022.

The Board of Directors of PerkinElmer, Inc. declared a regular quarterly dividend of $0.07 per share of common stock.

CANbridge Pharmaceuticals Inc. announced that the company’s partner Mirum Pharmaceuticals, Inc. reported positive topline data from its Phase 3 MARCH study evaluating the safety and efficacy of LIVMARLI® oral solution in patients with progressive familial intrahepatic cholestasis.

McKesson Corporation has opened a new state-of-the-art pharmaceutical distribution center in Jeffersonville, Ohio, centrally located between Cincinnati and Columbus.